Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysis

Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysis

Objectives: Sexual transmission of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) is suspected. We aimed to identify clusters of sexual behavior associated with ESBL-E carriage among individuals at risk of sexually transmitted infections (STI). Methods: In this cross-sectional stu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anders Boyd, Pauline Mathieu, Ugo Françoise, Hayette Rougier, Thibault Chiarabini, Nadia Valin, Karine Lacombe, Paul-Louis Woerther, Laure Surgers
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	International Journal of Infectious Diseases
Subjects:	Antimicrobial resistance Enterobacterales Sexually transmitted diseases Transmission Epidemiology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971224003485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Faecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing enterobacterales among HIV patients at Jimma Medical Center, Southwest Ethiopia
by: Dechasa Befikadu, et al.
Published: (2024-11-01)

Gastrointestinal carriage of carbapenemase-producing enterobacterales among inpatient and outpatient children in Kenya
by: Susan Githii, et al.
Published: (2024-12-01)

High prevalence of fecal carriage of extended-spectrum beta-lactamase producing Enterobacterales among patients with urinary tract infections in rural Tanzania
by: Magreth Erick Macha, et al.
Published: (2025-01-01)

Prevalence and determinants of faecal carriage of carbapenem- and third-generation cephalosporin-resistant Enterobacterales: a cross-sectional household survey in northern VietnamResearch in context
by: Max van Wijk, et al.
Published: (2025-01-01)

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
by: Tuğba Pamukçu, et al.
Published: (2024-12-01)

Characterization of Metallo β-Lactamase Producing <i>Enterobacterales</i> Isolates with Susceptibility to the Aztreonam/Avibactam Combination
by: Brunella Posteraro, et al.
Published: (2024-12-01)

Phenotypic and Genomic Characterization of ESBL- and AmpC-β-Lactamase-Producing <i>Enterobacterales</i> Isolates from Imported Healthy Reptiles
by: Franziska Unger, et al.
Published: (2024-12-01)

Prevalence and Molecular Characteristics of 16S rRNA Methylase Genes in Clinical Isolates of Carbapenem-Resistant Enterobacterales
by: Li C, et al.
Published: (2024-11-01)

Epidemiological and genetic characteristics of clinical carbapenemase-producing Enterobacterales isolates from Batna hospitals in Algeria
by: Amel Benbouza, et al.
Published: (2024-12-01)

Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales
by: Helio S. Sader, et al.
Published: (2024-11-01)

Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies
by: Jialiang Xu, et al.
Published: (2024-11-01)

Characterization of Enterobacterales growing on selective CPE screening plates with a focus on non-carbapenemase-producing strains
by: Reut Efrati Epchtien, et al.
Published: (2025-02-01)

Phenotypic versus molecular assays for detecting carbapenemase-producing Enterobacterales from urinary tract infections
by: Amina Nour El Deen, et al.
Published: (2024-11-01)

Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
by: Uma BM, et al.
Published: (2024-07-01)

Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
by: Luca Mezzadri, et al.
Published: (2024-12-01)

Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
by: Şevval Arduç Tok, et al.
Published: (2024-12-01)

Susceptibility of Enterobacterales Collected in the Middle East and Turkey to Aztreonam/Avibactam and Comparator Agents Stratified by Infection Source: ATLAS Surveillance Program 2018-2022
by: Mark Wise, et al.
Published: (2024-12-01)

Is intestinal colonization with multidrug-resistant Enterobacterales associated with higher rates of nosocomial Enterobacterales bloodstream infections?
by: Noureddine Henoun Loukili, et al.
Published: (2025-01-01)

Risk factors and molecular epidemiology of colonizing carbapenem-resistant Enterobacterales in pediatric inpatient in Shenzhen, China
by: Hongmei Yang, et al.
Published: (2025-01-01)

Spatiotemporal and genomic analysis of carbapenem resistance elements in Enterobacterales from hospital inpatients and natural water ecosystems of an Irish city
by: Mark Maguire, et al.
Published: (2025-01-01)

Impact of universal contact precautions and chlorhexidine bathing on the acquisition of carbapenem-resistant enterobacterales in the intensive care unit: a cohort study
by: Jongtak Jung, et al.
Published: (2024-11-01)

A comparison of two MALDI-TOF MS based assays for the detection of carbapenemases in Enterobacterales
by: Christine Uitz, et al.
Published: (2024-11-01)

Antimicrobial resistance of multidrug-resistant Enterobacterales and Acinetobacter baumannii isolates to colistin in a Moroccan hospital
by: Nadia El mrimar, et al.
Published: (2024-08-01)

Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study
by: Courtney M. Tubb, et al.
Published: (2025-01-01)

In Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales and Pseudomonas aeruginosa Collected in Turkey and the Middle East: ATLAS Global Surveillance Program 2018-2022
by: Meredith Hackel, et al.
Published: (2024-12-01)

In Vitro Activity of Aztreonam-avibactam and Comparator Agents Against Carbapenemase-producing Enterobacterales Collected in Turkey and the Middle East as Part of the ATLAS Surveillance Program: 2018-2022
by: Mark Estabrook, et al.
Published: (2024-12-01)

Emergence of plasmid-mediated tigecycline resistance tet(X4) gene in Enterobacterales isolated from wild animals in captivity
by: Lei Lei, et al.
Published: (2024-01-01)

Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis
by: Milo Gatti, et al.
Published: (2024-12-01)

Molecular epidemiology of carbapenemases in Enterobacterales in tertiary care hospital and comparison of three phenotypic carbapenemase detection methods
by: Mustafa Yılmaz, et al.
Published: (2024-12-01)

Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study
by: Sibongakonke Mbele, et al.
Published: (2025-02-01)

Integral genomic description of blaNDM-5-harbouring plasmids recovered from Enterobacterales in Argentina.
by: Francisco González-Espinosa, et al.
Published: (2024-12-01)

Isolation of Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum ß-lactamases from dog urine of the Metropolitan Area of the Aburrá Valley (Antioquia, Colombia)
by: A. M. Ochoa, et al.
Published: (2022-01-01)

Phenotypic detection of carbapenem-resistant Enterobacterales in clinical isolates at a tertiary care hospital
by: Astha Sinha, et al.
Published: (2024-01-01)

Development of a Recombinase Polymerase Amplification-Coupled CRISPR/Cas12a Platform for Rapid Detection of Antimicrobial-Resistant Genes in Carbapenem-Resistant <i>Enterobacterales</i>
by: Ji Woo Yang, et al.
Published: (2024-11-01)

World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational studyResearch in context
by: Laura C. Antochevis, et al.
Published: (2025-03-01)

Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022)
by: Helio S. Sader, et al.
Published: (2025-01-01)

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study
by: Yu CH, et al.
Published: (2024-12-01)

Extended-spectrum beta-lactamase-producing Enterobacterales in human health: Experience from the tricycle project, Ghana.
by: Noah Obeng-Nkrumah, et al.
Published: (2024-01-01)

Extended Spectrum Beta-Lactamase Carriage State among Elderly Nursing Home Residents in Beirut
by: M. A. Jallad, et al.
Published: (2015-01-01)

Asymptomatic enteric pathogen carriage and its association with proton pump inhibitors use in men who have sex with men in Taiwan, 2019-2022
by: Chin-Shiang Tsai, et al.
Published: (2024-12-01)